HealthSeptember 4, 2026
ropeginterferon
ROH-peg-in-TER-fuh-ron
Definition
A synthetic, long-acting interferon drug approved by the FDA as a therapy for blood conditions such as essential thrombocythemia.
Etymology
The name is a portmanteau derived from 'rope' (a chemical modification process that anchors a molecule to the drug) and 'interferon' (a group of signaling proteins released by the body in response to pathogens).
In the news
Ropeginterferon is introduced as the first new drug approved to treat essential thrombocythemia in nearly three decades, marking a significant update in blood cancer care.
Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win
Read the full article ↗MedPage Today